Lillie Charisse R 4

What Happened
Lillie Charisse R, a director of Exelon Corporation (EXC), received equity awards on 2026-03-31. The filing shows an award of 878 shares of common stock at $49.82 per share (value $43,742) and 5 phantom share equivalents at $49.02 each (value $245), for a combined acquisition value of approximately $43,987. These entries are coded A (grant/award).

Key Details

• Transaction date: 2026-03-31; filing date (Accession 0001972789-26-000004): 2026-04-01 (filed promptly).
• Awarded: 878 shares of common stock @ $49.82 (total $43,742) and 5 phantom share equivalents @ $49.02 (total $245).
• Total newly acquired units: 883 (878 actual shares + 5 phantom equivalents); combined value ≈ $43,987.
• Footnotes:
  • F1: Balance includes 98 additional shares acquired via automatic dividend reinvestment.
  • F2: The 5 units are phantom share equivalents held in a multi-fund non-qualified deferred compensation plan and will be settled for cash on a 1-for-1 basis upon termination of service.
  • F3: Balance includes 32 additional phantom share equivalents accrued through automatic dividend reinvestment.
• Transaction code: A = award/grant (not an open-market buy or sale). No late filing indicated.

Context
This was an equity award (compensation/retainer-related grant), which is routine for board members and not the same as an open-market purchase (a more direct bullish signal) or a sale. The small number of phantom units are derivative, representing cash-settled deferred compensation rather than immediate stock ownership.